chrisvoncsefalvay/vaers-outcomes huggingface dataset:
11/9/2021 - fever, chills, nausea, diarrhea  11/10/2021 to present - constant back pain
Anxiety due to the second shot being cancelled and no way to reschedule!  All appts are not accessible!!  Fix it and restore public trust, this sucks!
9:10 AM-vaccinated with MENACTRA, 9:30 AM paresthesia of left hand; resolved within minutes. 10:54 AM rash of left thumb, no pruritus, no chest pain, no SOB, no cough or wheeze; vs stable. On ALLEGRA, take BENADRYL once at home and course of steroids.
upper arm soreness; This is a spontaneous report from a contactable consumer (patient, self-reported). A 54-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 03Mar2021 at 15:15 PM (age at vaccination: 54 Years), as a single dose for COVID-19 immunization at workplace clinic. The patient's medical history Meniere's disease and spring allergies from pollen and mold. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination included Simvstatin, Lisinopril, and Tranmadol. Prior to vaccination, the was not patient diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient reported that on 04Mar2021, he experienced upper arm soreness. The patient became aware of these symptoms the day after the injection. The patient did not receive treatment for the adverse event. Outcome of the event was recovering.  Follow-up attempts are completed. No further information is expected.
Diarrhea/vomiting , fever/chills, dizzy, terrible headache
Left upper shoulder and arm immobility; Shoulder injury related to vaccine administration; Left shoulder pain; Wrong Injection Technique/Vaccine administered too high on deltoid muscle causing needle to hit bone and shoulder; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of injected limb mobility decreased in a 76-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number M4E4A, expiry date 05-OCT-2025) for prophylaxis.   On 08-JUN-2023, the patient received Boostrix (left deltoid). On 08-JUN-2023, less than a day after receiving Boostrix, the patient experienced injected limb mobility decreased (Verbatim: Left upper shoulder and arm immobility), shoulder injury related to vaccine administration (Verbatim: Shoulder injury related to vaccine administration), shoulder pain (Verbatim: Left shoulder pain) and wrong injection technique (Verbatim: Wrong Injection Technique/Vaccine administered too high on deltoid muscle causing needle to hit bone and shoulder). The patient was treated with AMBIGUOUS MEDICATION NOS (CORTISONE (NOS)). The outcome of the injected limb mobility decreased, shoulder injury related to vaccine administration and shoulder pain were not resolved and the outcome of the wrong injection technique was unknown.   It was unknown if the reporter considered the injected limb mobility decreased, shoulder injury related to vaccine administration and shoulder pain to be related to Boostrix and Boostrix Pre-Filled Syringe Device.     It was unknown if the company considered the injected limb mobility decreased, shoulder injury related to vaccine administration and shoulder pain to be related to Boostrix and Boostrix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 29-JUN-2023 The reporter was pharmacist called as a customer on behalf of his father. Reporter states that his father received the BOOSTRIX vaccine on 08-JUN-2023 at his pharmacy.  Reporter father got 9 other vaccines at the same pharmacy in the past.  Reporter stated that his father had pain in his left shoulder immediately after BOOSTRIX injection in his left deltoid and left shoulder. Also his father had left shoulder and arm immobility.  Caller took his father to his doctor on 21-JUN-2023 when he was diagnosed with SIRVA. Caller reported that the doctor said vaccine administered too high on deltoid muscle causing needle to hit bone and shoulder.  Reporter stated that the doctor recommended father go to an Orthopedic Specialist for Cortisone injections in his left shoulder. Reporter also stated that doctor believes these symptoms may not go away for 6 months to a year and a half.  The reporter consented to follow up.
Patient was administered her 1st dose of Pfizer Covid Vaccine  and while waiting for her 15 minutes observation, she started feeling dizziness and passed out.  911 was called and she was taken to the hospital
Dry skin on face; Dry skin on hairline to her neck / Dry skin on collar bone; Redness in the area from her neck to collar bone; This spontaneous case was reported by a consumer and describes the occurrence of DRY SKIN (Dry skin on face), DRY SKIN (Dry skin on hairline to her neck / Dry skin on collar bone) and ERYTHEMA (Redness in the area from her neck to collar bone) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL and HYDROCHLOROTHIAZIDE for Hypertension, POTASSIUM for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DRY SKIN (Dry skin on face), DRY SKIN (Dry skin on hairline to her neck / Dry skin on collar bone) and ERYTHEMA (Redness in the area from her neck to collar bone). At the time of the report, DRY SKIN (Dry skin on face), DRY SKIN (Dry skin on hairline to her neck / Dry skin on collar bone) and ERYTHEMA (Redness in the area from her neck to collar bone) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not take any medications for skin problems, but used face cream to soothe the affected skin.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: No new information was provided.
Onset of vomiting and bloody stool 3-4 hours after administration of vaccines. Patient seen in emergency room and diagnosed with intussusception, reduced with air enema. 12/19/06 Received medical records from ER which reveal patient seen 11/06/06 s/p vomiting & bloody stool on day of vax.  Afebrile.  Lethargic.  Hypoactive bowel sounds & palpable soft mass in RUQ with tenderness to palpation.  Seen in ER at outlying hospital then transferred to facility which could provide air contrast enema.  Kept in that ER for several hours s/p successful reduction for continued observation. Final DX: Intussusception, reduced by air enema.
light headed, nausea, anxiety - All resolved before pt. drove away;   BP=124/68;  HR=62; O2=97;
No additional AE/PQC reported.; Admisnistration of VARIVAX and PROQUAD at the same time.; This spontaneous report was received from a certified medical assistant and refers to a 1-year-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were provided.  On 08-JAN-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (for both lot #, expiration date, route and site of administration were not provided) at the same time for prophylaxis (Overdose). The vaccines were reconstituted with sterile diluent (STERILE DILUENT) (dose, route of administration, lot # and expiration date were not provided). The reporter did not know, if there were any adverse event, however no additional adverse event was reported at that time. The outcome of the overdose was unknown.
First shot Pfizer, 2nd shot Moderna Booster mix series; Moderna Booster half dose administered instead of second shot Pfizer; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot Pfizer, 2nd shot Moderna Booster mix series) and ACCIDENTAL UNDERDOSE (Moderna Booster half dose administered instead of second shot Pfizer) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer COVID-19 Vaccine on 17-Sep-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 Vaccine.    On 24-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot Pfizer, 2nd shot Moderna Booster mix series) and ACCIDENTAL UNDERDOSE (Moderna Booster half dose administered instead of second shot Pfizer). On 24-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot Pfizer, 2nd shot Moderna Booster mix series) and ACCIDENTAL UNDERDOSE (Moderna Booster half dose administered instead of second shot Pfizer) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment mediations were reported.
Joint Pain, Arm Pain near injection site, chills, not taking anything for pain, but will take acetominophen tonight so I can sleep
Patient lost consciousness while sitting in chair after vaccine. She also urinated on herself while passed out.  Duration of unconsciousness not known for sure. She came to and was noticed to be sweating and pale. We gave her water, a snack, and a fan. Patient felt better within 15  minutes.
3x4 red-hard-hot cellulitis-topical hydrocortisone 1%;to see again Monday;
This spontaneous report was received from a patient's mother who was referring to her 18 year old son. The patient had no medical history, concomitant medications, drug reactions or allergies. On 16-MAR-2016, the patient was vaccinated with GARDASIL or GARDASIL 9 dose 1, intramuscularly for prophylaxis (lot number and expiration date were not provided). In March 2016 (reported as within a week), the patient experienced extreme fatigue and upset stomach. Over the course of the past 14 months, the patient lost over 30 pounds and continued to feel tired. It was also reported that the patient had trouble with concentrating on school work. The reporter did not provide demographics for a physician, as the patient no longer visited the pediatrician who administered the vaccine injection. It was also reported that the patient received only first dose of three doses of GARDASIL or GARDASIL 9. The patient sought medical attention and was seen by several specialists. He had many unspecified types of tests done and was scheduled for a few more tests. There was no treatment given for an adverse events. The patient's present status was not recovered. The relatedness between the events and GARDASIL or GARDASIL 9 was not reported. Additional information is not expected as there was no consent for follow-up.
Moderna COVID?19 Vaccine EUA I reported joint pain, general malaise, headaches, and fatigue.  This event I did not include because I initially believe it was environment from my work context. I had initial rashes on lower limbs near ankles like hiker's rash within a couple weeks of the second dose of the Moderna vaccine. Fatigue and malaise continued during this time. Over the next week vesicles and bullae formed and continued to rupture and form on my legs, ankles, and feet. This has continued over the past eight weeks. I, the patient, treated the rash and blisters with cold showers and epsom salt baths because I thought it was work related. I have continued to have new blisters, and decided to report the event to VAERS because changes in my routine have not changed the presence of the blisters.
Pt developed SOB, nausea, diarrhea, lightheadedness, and lumps in arms and legs
pt was fussy 28OCT but no fever;this AM woke up w/whelps on face both temple areas, cheeks & chin;
finger flange that was noted to be broken off; she was cut by a sharp edge from the finger flange; she was cut by a sharp edge from the finger flange; This spontaneous report as received from an other health professional refers to a 53-year-old female patient. No information on patient medical history, current conditions and concomitant medications was provided.      On 16-MAY-2023 the patient was occupationally exposed to hepatitis b vaccine (recombinant) (RECOMBIVAX HB) lot # W022795 and expiration date 19-MAY-2025 (exact dose 0.5 millilter) (syringe issue and Injury associated with device )   On 16-MAY-2023, the medical assistant experienced skin laceration. Provided treatment for skin laceration was band aid. The outcome of skin laceration was reported as recovered. Action taken with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) regarding the event was not applicable.   The causality between the hepatitis b vaccine (recombinant) (RECOMBIVAX HB) and the event was not provided.
This initial spontaneous case, was received from a pharmacist on 26-Oct-2017, concerning a male patient of unspecified age. On 05-Oct-2017, the patient was administered with FLUVIRIN (dose: 0.5 ml, route of administration: Intramuscular, anatomical location: left Deltoid, batch number: 179705P, expiry date: not reported). On 07-Oct-2017 after 3 days of vaccination, he had soreness in his arm. On an unspecified date, the event was improved. The reporter assessed the event as non-serious. Follow up information was received on 28-Nov-2017. Event onset date was added (07-Oct-2017). Outcome was updated from not recovered to improved. Narrative was amended accordingly.
Extreme sore arm after vaccine that went down.  Then 7 days later, same area covered with bumpy rash like welts.  Still hard. The area is below the injection site.  Otherwise, feel kind of low flu-ish. Felt fine first week.  Then on day 7 rash and feeling off.  Maybe an immune response.
became confused about 1hr p/vax;fever unreliable for reading thermometer accurately for 24hr;
Client called the health dept 6/10/15. All of the history is described by the client and is as follows and states she developed GBS 1 week before thanksgiving 2011. She was diagnosed at health care center after a spinal tap was done. States her feet were numb and couldn't maintain balance and had terrible pain in her back to abdomen. She then went to hospital by ambulance. Then she was transferred to rehabilitation. She states she is still having residual effects and was forced to retire. The client states she has had several flu shots in the past and has no allergies and received the VIS statement. She states she didn't realize there is a vaccine adverse event reporting system.
Received a Moderna Covid-19 vaccine Booster dose more than 12 hours post punctured; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a Moderna Covid-19 vaccine Booster dose more than 12 hours post punctured) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083J21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 12-Mar-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a Moderna Covid-19 vaccine Booster dose more than 12 hours post punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a Moderna Covid-19 vaccine Booster dose more than 12 hours post punctured) outcome was unknown.            Patient took Moderna vaccine on deltoid muscle. No concomitant and treatment  medication was reported by the reporter.   This case was linked to MOD-2022-512457 (Patient Link).   Reporter did not allow further contact
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions and medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9, lot # M041990 with expiration date on 28-JUN-2019 and lot # M042853 with expiration date on 17-JUL-2019 (dose was not reported). There was no adverse effect reported. Administered doses of the vaccine experienced the temperature excursion of 70 degrees Fahrenheit for 1 hour. Data logger was not involved in recording of the temperature excursion. There were no previous excursions reported. This is one of the several reports received from the same reporter. Additional information is not expected as there was no permission for further contact. Sender's Comments: US-009507513-1706USA010605: US-009507513-1706USA010618.
Fairly severe joint pain started on 06Feb, worse today, esp. in shoulders which are quite arthritic; This is a spontaneous report from a contactable consumer (patient herself) A 65-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN53.8),via an unspecified route of administration, administered in Arm Left on 03Feb2021 (Batch/Lot Number: EN5318) as SINGLE DOSE for covid-19 immunisation .Medical history included osteoarthritis from an unknown date and unknown if ongoing , hypertension from an unknown date and unknown if ongoing ,obesity from an unknown date and unknown if ongoing.The patient's concomitant medications were not reported.  The patient experienced fairly severe joint pain started on 06feb, worse today, esp. in shoulders which are quite arthritic on 06Feb2021 07:00 with outcome of not recovered.I would have been happy to help had you bothered to generate a fillable .pdf but I'm not going to try to hand write everything. This is the 21st century, time to get with the program.The events were considered as non-serious by the consumer. The outcome of the events was not recovered.    No follow up attempts are possible. No further information is expected.
Information has been received from a pharmacist via a field representative referring to a male patient in his seventies. Information about about medial history, concurrent condition and concomitant medication was not reported. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (strength, dosage, frequency and route unspecified). On an unspecified date in 2015 (reported as "within the last few weeks") the patient received an unspecified flu vaccine. On an unknown date, six days after receiving PNEUMOVAX23, the patient had unspecified redness and swelling at the injection site. The outcome of the events was unknown. Additional information has been requested.
Now it's all over my neck and body and chest area; rash all over your body, with hives and redness; rash all over your body, with hives and redness; rash all over your body, with hives and redness; Fatigue; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Muscle pain), RASH (rash all over your body, with hives and redness), URTICARIA (rash all over your body, with hives and redness) and ERYTHEMA (rash all over your body, with hives and redness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FATIGUE (Fatigue) and MYALGIA (Muscle pain). On 14-Feb-2021, the patient experienced RASH (rash all over your body, with hives and redness), URTICARIA (rash all over your body, with hives and redness) and ERYTHEMA (rash all over your body, with hives and redness). On 15-Feb-2021, the patient experienced RASH (Now it's all over my neck and body and chest area). At the time of the report, FATIGUE (Fatigue), MYALGIA (Muscle pain) and RASH (Now it's all over my neck and body and chest area) outcome was unknown and RASH (rash all over your body, with hives and redness), URTICARIA (rash all over your body, with hives and redness) and ERYTHEMA (rash all over your body, with hives and redness) had resolved.      Treatment information included Benadryl (diphenhydramine HCL).
"feels like I got run over by a Mac truck"; headache; tingling to left hand; face warm; flushed; This is a spontaneous report from a non-contactable Physician. An adult female patient of unspecified age received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Jan2021 Intramuscular into left arm as single dose for COVID-19 immunisation.  Medical history and concomitant medication were not reported. The patient was not pregnant at the time of vaccination. Patient did not have Covid prior vaccination. The patient did not have Covid tested post vaccination.  It is not known if patient received other vaccine in last four weeks.  Immediately after injection (18Jan2021), small amount of tingling to left hand, face warm, flushed was experienced and resolved within 30 minutes without intervention.  The patient experienced "feels like I got run over by a Mac truck" on 19Jan2021 and headache on 19Jan2021.  It was unknown if treatment was received.  Outcome of event "feels like I got run over by a Mac truck" was recovered, 'headache' was recovered, 'small amount of tingling to left hand' was recovered, 'face warm' was recovered and 'flushed' was recovered.    The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
One day after zostavax was administered to this patient, she called the pharmacy to talk about her "swelling arm". I asked the patient to come into the pharmacy so I could examine the injection site. The back of her left arm, where the injection was given, was slightly raised from swelling and red in an uneven circle. The diameter of the red spot was approximately 1 and 1/2 inches. I told the patient she was suffering from an injection site reaction, and not to worry terribly. I advised her to take two 500mg tablets of acetaminophen to help relieve any pain is she was experiencing any. I also told her to follow up with her physician if the area of reness got bigger and if her arm began to swell even more.
Onset of symptoms 2am (on 10/21/20) with her waking up to heart palpitations, hands and lips tingling , weak sensation and heaviness of arms, dizzy, chills, shivering, headache, and a cough. The bulk of the symptoms lasted until about 6 am-  She notified the clinic  around 9:30am - She reported at that time having a headache and chills.  Patient reports that each day she felt somewhat better- but continued to have chills -  The chills resolved  on the 6th day. (10/26/20)  Symptoms resolved completely 10/27/20